Aims and Scope
Instructions for Authors
Instructions for Reviewers
Ahead of Print
Most Read Articles
Most Cited Articles
Korean J Intern Med Search
> Browse Articles > Korean J Intern Med Search
Clinical factors affecting progression-free survival with crizotinib in
-positive non-small cell lung cancer
Chan-Young Ock, Shin-Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Doo Hyun Chung, Dae Seog Heo
Korean J Intern Med.
2019;34(5):1116-1124. Published online June 29, 2018
Cited By 1
Background/Aims: Although crizotinib is standard chemotherapy for advanced anaplastic lymphoma kinase (
)-positive non-small cell lung cancer (NSCLC), clinical factors affecting progression-free survival (PFS) have not been reported. The purpose of this study was to identify clinical factor..
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6792 Fax: +82-2-790-0993 E-mail:
Copyright © 2019 The Korean Association of Internal Medicine. All rights reserved.
For Authors and Reviewers